Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Oct 8;8(19):5225-5226.
doi: 10.1182/bloodadvances.2024013815.

Hydroxyurea and follicle density in sickle cell

Susan Creary  1 , Chelsea Kebodeaux  2 , Leena Nahata  1
Affiliations
Comment

Hydroxyurea and follicle density in sickle cell

Susan Creary et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Comment on

  • Impact of hydroxyurea on follicle density in patients with sickle cell disease.
    Diesch-Furlanetto T, Sanchez C, Atkinson A, Pondarré C, Dhedin N, Neven B, Arnaud C, Kamdem A, Pirenne F, Lenaour G, Brocheriou I, Terris B, Bernaudin F, Dalle JH, Poirot C. Diesch-Furlanetto T, et al. Blood Adv. 2024 Oct 8;8(19):5227-5235. doi: 10.1182/bloodadvances.2023011536. Blood Adv. 2024. PMID: 39023361 Free PMC article.

References

    1. Deisch-Furlanetto T SC, Atkinson A, Pondarre C, et al. Impact of hydroxyurea on follicle density in patients with sickle cell disease. Blood Adv. 2024;8(19):5227–5235. - PubMed
    1. Pecker LH, Hussain S, Christianson MS, Lanzkron S. Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide. Br J Haematol. 2020;191(5):880–887. - PMC - PubMed
    1. Elchuri SV, Williamson RS, Brown RC, et al. The effects of hydroxyurea and bone marrow transplant on anti-Müllerian hormone (AMH) levels in females with sickle cell anemia. Blood Cells Mol Dis. 2015;55(1):56–61. - PubMed
    1. Hankins J, Hinds P, Day S, et al. Therapy preference and decision-making among patients with severe sickle cell anemia and their families. Pediatr Blood Cancer. 2007;48(7):705–710. - PubMed
    1. Pecker LH, Maher JY, Law JY, Beach MC, Lanzkron S, Christianson MS. Risks associated with fertility preservation for women with sickle cell anemia. Fertil Steril. 2018;110(4):720–731. - PubMed